Performance

Following a several-year effort to correct an overallocated exposure to PE, early indications from council hint at plans for more reductions ahead of next year’s asset allocation process.

Nordic Capital's Fund XII intends to make equity investments between €250m and €1bn across four key sectors.

While many GPs have been optimistic despite the recent slump in private equity activity, some in the industry are concerned that the asset class's issues are more than temporary.

The PE portfolio's growth in FY2025 appears to be its largest jump since FY2021.

WindRose Health Investors VII is set to raise 27% more than its predecessor, closed in 2023 at more than $1.4bn.

EQT continues to put up strong exit numbers, defying a broader drought. Plus: Apollo taps a Japanese LP heavyweight to lead its Asia business; and a big Australian investor gets a new private markets head. Here's today's brief, for our valued subscribers only.

The Boston manager is aiming to hold a 'significant' first close for BV Investment Partners Fund XII in December, pension documents said.

In keeping with past practice, Brookfield will make a hefty commitment alongside Fund VII’s LPs, totaling $3.5bn, sources told Buyouts.

The indices are designed to address market participants’ demand for clarity around performance and volatility.

Nearly a quarter of capital commitments for Freya XII came from US investors.